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Results: 21 pts (9%) presented with type 1 in at least 1 peripheral leads:
16 pts (7%) in aVR lead, 5 pts in inferior leads and none in lateral leads. Type
1 in limb leads was associated with a type 1 in right precordial leads in each
pt, and was spontaneous in 8 pts (38%) and induced by drug challenge in
13 pts (62%). 15 of them have results of genetic testing (7 had SCN5A mutation).
There was a trend toward longer PR interval in patients with type 1 ECG
in limb leads (192±39 ms vs 176±35ms, p=0.09).
These patients present more frequently with arrhythmic events (57% vs
33%, p=0.009), with syncope (48% vs. 26%, p=0.0002), ICD appropriated
therapies (24% vs. 6%, p<0.001) and a trend toward more frequent SD (10%
vs 4%, p=0.1).
In multivariate analysis, type 1 ECG in limb leads was independently asso-
ciated with arrhythmic events (OR 3.08, [1.17-8.1], p=0.022) or with SD or
appropriate ICD therapy (OR 4.5 [1.32-15.3], p=0.016).
Conclusion: Type 1 Brugada pattern in peripheral limb ECG leads can be
seen in around 10% in patients with BS, mostly in aVR lead but also in infe-
rior leads. Type 1 ST elevation in limb leads is an independent predictive
factor of arrhythmic event in BS patients. This simple ECG parameter could
be used for further risk stratification.
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Introduction: Risk stratification in Brugada syndrome (BS) remains a key
issue. Cardiac autonomic dysfunction has been proposed as a precipitating
factor of arrhythmic events in BS. The aim of the present study was to assess
cardiac response to autonomic innervation using heart rate variability (HRV),
in symptomatic patients with a BS compared to asymptomatic patients.
Methods: Twenty-two patients with BS were studied. Group S (mean
age=45.5±11 years, men: n=9) consisted of 10 symptomatic patients (3 cardiac
arrest, 4 syncope, 1 nocturnal convulsions and 2 lipothymia) and group A
(mean age=39.9±13.9 years, men: n=5) of 12 asymptomatic patients. HRV
was obtained, using dedicated software, on 24 hours Holter recording. We
studied time and frequency domains during a day-period (16h-20h) and a
night-period (0h-4h), using mean values and variation coefficients for each
period.
Results: In time and frequency domain, no difference was found between
the 2 groups, during the whole recording, night or day period. During night
period, patients from group S have higher variations than patients from group
A for HFn.u. (45.9±10.5 vs 34.6±13%, p<0.05) and LF/HF (56.7±10.7 vs
44.2±18, p<0.05). No difference was found during day. This higher variation
of frequency domain parameters during night in symptomatic patients relates
a more variable sinusal node response to the cardiac autonomic innervation.
Conclusion: Symptomatic patients with BS have higher variations of car-
diac response to the autonomic innervation during night resulting from either
higher sinus node sensitivity to autonomic influx or higher variation of these
influxes. The occurrence of symptoms in BS will be underlined by sponta-
neous higher variations of cardiac response to autonomic nervous system
especially during night.
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Introduction: Antitachycardia pacing (ATP) is a painless therapy reducing
shocks in implantable cardioverter-defibrillator (ICD) recipients. One or 2 ATP
attempts are usually programmed to terminate fast ventricular tachycardia (FVT)
episodes without delaying successful shock if ATP fails. Programming more ATP
attempts could probably reduce the occurrence of shocks.
Objective: We sought to analyze the long-term efficacy and safety of pro-
gramming a high number of ATP attempts for FVT.
Methods: Patients receiving a first ICD for coronary artery disease and
dilated cardiomyopathy in primary and secondary prevention indications
between 2000 and 2009 were prospectively included. ICDs were programmed
to deliver 10 ATP attempts for FVT cycle lengths (CL) of 250 to 300 ms (200
to 240 bpm) before shock delivery (5 bursts then 5 ramps; 10 pulses at 81 to
88% of the FVT CL; minimal pacing CL 180 ms).
Results: 770 patients were prospectively included and followed for
40±25 months. Among them, 137 patients (17.8%) had a total of 1839 epi-
sodes of FVT (rate 209±9 bpm). ATP terminated 1713 episodes of FVT (effi-
cacy, 93.1%) and accelerated 5.8% of episodes. A majority of episodes were
successfully treated (98.3%) by 1 or 2 ATP attempts. Conversely, the patient-
based analysis showed that 17 (12.4%), 8 (5.8%) and 5 patients (2.1%) had
one episode or more treated by at least 3, 4 or 5 ATP attempts, respectively.
These patients would have been shocked with a conventional ICD program-
ming. The benefit of this strategy was reduced for 6 to 10 attempts and only
10 patients were shocks for ATP failure (20 episodes, 1.1%). Despite the high
number of attempts programmed, FVT episodes were mainly asymptomatic
and found during device interrogation: syncope and pre-syncope occurred in
0.2% and 0.4% of episodes, respectively.
Conclusion: Programming a high number of ATP attempts (at least 4 or 5
ATP attempts) for FVT is both safe and useful. It could prevent painful shocks
in a high proportion of ICD recipients.
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Introduction: the assessment of the arrhythmia risk is an important issue
after myocardial infarction (MI). The role of autonomic nervous system in
arrhythmia stratification risk is well validated. Holter parameters can reflect
both components of the autonomic nervous system: the sympathic and the
parasympathic. There is little data concerning the relation between risk strati-
fication parameters and the MI localization.
Aim: Comparison of Holter parameters exploring the autonomic nervous
system in patients having anterior and inferior myocardial infarction.
Methods: This prospective study included 90 patients (mean age 58±10 years)
hospitalized for recent myocardial infarction who underwent 24 hour Holter
monitoring. We analysed the number of premature beats(PB), heart rate vari-
ability (HRV) parameters (SDNN, RMSSD), QT intervals and heart rate tur-
bulence (TO et TS)
Results: 50 patients had anterior MI and 40 patients had inferior MI. There
was no significant difference between both groups regarding HRV and heart
rate turbulence. Where as in patients having anterior MI the QT interval was







Number PB/ 24H 46±8 52±8 NS
SDNN 92±39 104±34 NS
RMSSD 40±20 36±21 NS
QT apex 349±27 340±22 NS
QT end 431±33 416±24 0.03
TO – 0.011 – 0.007 NS
TS 8.41 9.37 NS
